Catherine Marti, MD
Advanced Heart Failure and Transplant Cardiology · Athens, GANPI 1124203989
Payments from drug & device makers
Across 616 payments — averaging $1058.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$173K
- Endotronix, Inc.$124K
- AstraZeneca$110K
- Pfizer$92K
- Novartis$56K
- Merck$43K
- plus $54K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 102 | $172,596 |
| Endotronix, Inc. | 4 | $124,145 |
| AstraZeneca | 105 | $110,092 |
| Pfizer(2 entities) | 80 | $92,343 |
| Novartis | 157 | $55,743 |
| Merck | 45 | $42,548 |
| American Regent | 5 | $17,632 |
| Boehringer Ingelheim | 24 | $16,820 |
| Bayer | 4 | $9,634 |
| Lilly USA, LLC | 4 | $4,050 |
| Lexicon Pharmaceuticals, Inc. | 9 | $3,216 |
| Amgen | 12 | $1,065 |
| Cvrx, Inc. | 9 | $600 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $268 |
| E.r. Squibb & Sons, L.L.C. | 10 | $179 |
| Briohealth Solutions, Inc. | 1 | $154 |
| Heartflow, Inc. | 2 | $145 |
| Biotronik Inc. | 1 | $135 |
| Alnylam Pharmaceuticals Inc. | 6 | $124 |
| Medtronic | 1 | $122 |
| Johnson & Johnson | 5 | $75 |
| Actelion Pharmaceuticals US, Inc. | 3 | $60 |
| Scpharmaceuticals Inc. | 2 | $37 |
| Boston Scientific | 2 | $30 |
| Edwards Lifesciences | 1 | $23 |
| Atricure, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
| Argon Medical Devices, Inc. | 1 | $16 |
| Bridgebio Pharma, Inc. | 1 | $14 |
| Akcea Therapeutics, Inc. | 1 | $14 |
How this compares
$651,920 in reported general payments places this provider in the 90th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Athens
- Chad MaoAtlanta$1.3M
- Andrew DarlingtonFayetteville$1.1M
- Darshak KariaAugusta$908K
- Ugochukwu EgolumGainesville$499K
- Andrew SmithAtlanta$413K
- Alanna MorrisGainesville$370K
- Abdul Latif BikakMarietta$274K
- Robert ColeAtlanta$239K
- Arthur ChandlerAugusta$226K
- Rahul LounganiAtlanta$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.